CAMBRIDGE, MA, Pandion Therapeutics announced that it has closed an $80 million Series B financing led by Access Biotechnology and Boxer Capital. Read More
CAMBRIDGE, MA, iTeos Therapeutics announced the closing of an oversubscribed $125M Series B2 financing, co-led by RA Capital Management and Boxer Capital. Read More